Buyer Name: NHS ENGLAND
Buyer Address: NHS England, 7&8 Wellington Place, Leeds, UKE42, LS1 4AP, United Kingdom
Contact Name: Balram Kullootee
Contact Email: b.kullootee@nhs.net
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025
Buyer Contact Info
Status
complete
complete
Procedure
open
open
Value
688834174.0 GBP
688834174.0 GBP
Published
01 Aug 2025, 10:49
01 Aug 2025, 10:49
Deadline
n/a
n/a
Contract Start
01 Dec 2025, 00:00
01 Dec 2025, 00:00
Contract End
31 May 2027, 22:59
31 May 2027, 22:59
Category
n/a
n/a
CPV
33600000 - Pharmaceutical products
33600000 - Pharmaceutical products
Region
n/a
n/a
Awarded To
ABBVIE LTD, ALIMERA SCIENCES LIMITED, BIOGEN IDEC LIMITED, ROCHE PRODUCTS LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED, ORION PHARMA (UK) LIMITED, Outlook Therapeutics, Inc., TEVA UK LIMITED, THORNTON & ROSS LIMITED, BAYER PUBLIC LIMITED COMPANY, Biosimilar Collaborations Ireland Limited, CELLTRION HEALTHCARE UNITED KINGDOM LIMITED, MDBIOLOGICS LTD, SANDOZ LIMITED
ABBVIE LTD, ALIMERA SCIENCES LIMITED, BIOGEN IDEC LIMITED, ROCHE PRODUCTS LIMITED, NOVARTIS PHARMACEUTICALS UK LIMITED, ORION PHARMA (UK) LIMITED, Outlook Therapeutics, Inc., TEVA UK LIMITED, THORNTON & ROSS LIMITED, BAYER PUBLIC LIMITED COMPANY, Biosimilar Collaborations Ireland Limited, CELLTRION HEALTHCARE UNITED KINGDOM LIMITED, MDBIOLOGICS LTD, SANDOZ LIMITED
Official Source
Open Find a Tender
Open Find a Tender
Description
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 Offer reference number: CM/PHS/25/5728 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement: CM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments: 7NAT (National) 01/12/2025 to 31/05/2027 (18 months) CM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg: NOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) SOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) MAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months) LNW: (London) 01/12/2025 to 31/05/2027 (18 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England Provision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; • neovascular (wet) age-related macular degeneration (AMD) • visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO) • proliferative diabetic retinopathy (PDR) • visual impairment due to diabetic macular oedema (DME) • visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy • vision impairment associated with chronic diabetic macular oedema, (DME) • visual impairment due to myopic choroidal neovascularisation (myopic CNV) • retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease • inflammation of the posterior segment of the eye presenting as non-infectious uveitis • prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye
Linked Documents
No linked documents found for this notice.
Opportunity Context
Lots
Lot 1 Status: complete
Lot 2 Status: complete
Awards
Award Title: Lot 1 - CM/PHS/25/5728/01
Award Title: Lot 2 - CM/PHS/25/5728/02
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"aboveThreshold": true,
"assessmentSummariesDateSent": "2025-07-31T00:00:00+01:00",
"contractPeriod": {
"endDate": "2027-05-31T23:59:59+01:00",
"maxExtentDate": "2029-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z"
},
"date": "2025-07-31T00:00:00+01:00",
"documents": [
{
"datePublished": "2025-08-01T11:49:34+01:00",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "045153-2025",
"noticeType": "UK6",
"url": "https://www.find-tender.service.gov.uk/Notice/045153-2025"
}
],
"hasRenewal": true,
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKE"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2025-08-18T23:59:59+01:00",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"1"
],
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"standstillPeriod": {
"endDate": "2025-08-13T23:59:59+01:00"
},
"status": "pending",
"suppliers": [
{
"id": "GB-COH-08004972",
"name": "ABBVIE LTD"
},
{
"id": "GB-COH-08018355",
"name": "ALIMERA SCIENCES LIMITED"
},
{
"id": "GB-COH-01497267",
"name": "BIOGEN IDEC LIMITED"
},
{
"id": "GB-COH-00100674",
"name": "ROCHE PRODUCTS LIMITED"
},
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
},
{
"id": "GB-COH-02281057",
"name": "ORION PHARMA (UK) LIMITED"
},
{
"id": "GB-COH-08179857",
"name": "Outlook Therapeutics, Inc."
},
{
"id": "GB-COH-00302461",
"name": "TEVA UK LIMITED"
},
{
"id": "GB-COH-00185947",
"name": "THORNTON \u0026 ROSS LIMITED"
},
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
],
"title": "Lot 1 - CM/PHS/25/5728/01",
"value": {
"amount": 688834174,
"amountGross": 826601009,
"currency": "GBP"
}
},
{
"aboveThreshold": true,
"assessmentSummariesDateSent": "2025-07-31T00:00:00+01:00",
"contractPeriod": {
"endDate": "2027-05-31T23:59:59+01:00",
"maxExtentDate": "2029-05-31T23:59:59+01:00",
"startDate": "2025-12-01T00:00:00Z"
},
"date": "2025-07-31T00:00:00+01:00",
"documents": [
{
"datePublished": "2025-08-01T11:49:34+01:00",
"description": "Contract award notice on Find a Tender",
"documentType": "awardNotice",
"format": "text/html",
"id": "045153-2025",
"noticeType": "UK6",
"url": "https://www.find-tender.service.gov.uk/Notice/045153-2025"
}
],
"hasRenewal": true,
"id": "2",
"items": [
{
"additionalClassifications": [
{
"description": "Pharmaceutical products",
"id": "33600000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKC"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKD"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKE"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKF"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKG"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKH"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKI"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKJ"
},
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UKK"
}
],
"id": "2",
"relatedLot": "2"
}
],
"mainProcurementCategory": "goods",
"milestones": [
{
"dueDate": "2025-08-18T23:59:59+01:00",
"id": "1",
"status": "scheduled",
"type": "futureSignatureDate"
}
],
"relatedLots": [
"2"
],
"renewal": {
"description": "option or options to extend (at the discretion of the Authority) up to maximum of 24 months."
},
"standstillPeriod": {
"endDate": "2025-08-13T23:59:59+01:00"
},
"status": "pending",
"suppliers": [
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "Biosimilar Collaborations Ireland Limited"
},
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
},
{
"id": "GB-COH-15579040",
"name": "MDBIOLOGICS LTD"
},
{
"id": "GB-COH-01547204",
"name": "SANDOZ LIMITED"
},
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
],
"title": "Lot 2 - CM/PHS/25/5728/02",
"value": {
"amount": 782917972,
"amountGross": 939501566,
"currency": "GBP"
}
}
],
"bids": {
"details": [
{
"id": "1",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08004972",
"name": "ABBVIE LTD"
}
]
},
{
"id": "2",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08018355",
"name": "ALIMERA SCIENCES LIMITED"
}
]
},
{
"id": "3",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-01497267",
"name": "BIOGEN IDEC LIMITED"
}
]
},
{
"id": "4",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00100674",
"name": "ROCHE PRODUCTS LIMITED"
}
]
},
{
"id": "5",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00119006",
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
}
]
},
{
"id": "6",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02281057",
"name": "ORION PHARMA (UK) LIMITED"
}
]
},
{
"id": "7",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-08179857",
"name": "Outlook Therapeutics, Inc."
}
]
},
{
"id": "8",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00302461",
"name": "TEVA UK LIMITED"
}
]
},
{
"id": "9",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00185947",
"name": "THORNTON \u0026 ROSS LIMITED"
}
]
},
{
"id": "10",
"relatedLots": [
"1",
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-00935048",
"name": "BAYER PUBLIC LIMITED COMPANY"
}
]
},
{
"id": "11",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-PPON-PQQC-5869-LMVX",
"name": "Biosimilar Collaborations Ireland Limited"
}
]
},
{
"id": "12",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-11685363",
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED"
}
]
},
{
"id": "13",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-15579040",
"name": "MDBIOLOGICS LTD"
}
]
},
{
"id": "14",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-01547204",
"name": "SANDOZ LIMITED"
}
]
},
{
"id": "15",
"relatedLots": [
"1"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-10015046",
"name": "ORIFARM UK LTD"
}
]
},
{
"id": "16",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02619880",
"name": "MERCURY PHARMACEUTICALS LIMITED"
}
]
},
{
"id": "17",
"relatedLots": [
"2"
],
"status": "valid",
"tenderers": [
{
"id": "GB-COH-02354269",
"name": "AMGEN LIMITED"
}
]
}
],
"statistics": [
{
"id": "1",
"measure": "bids",
"relatedLot": "1",
"value": 11
},
{
"id": "2",
"measure": "bids",
"relatedLot": "2",
"value": 7
},
{
"id": "3",
"measure": "finalStageBids",
"relatedLot": "1",
"value": 11
},
{
"id": "4",
"measure": "smeFinalStageBids",
"relatedLot": "1",
"value": 4
},
{
"id": "5",
"measure": "vcseFinalStageBids",
"relatedLot": "1",
"value": 0
},
{
"id": "6",
"measure": "finalStageBids",
"relatedLot": "2",
"value": 7
},
{
"id": "7",
"measure": "smeFinalStageBids",
"relatedLot": "2",
"value": 1
},
{
"id": "8",
"measure": "vcseFinalStageBids",
"relatedLot": "2",
"value": 0
}
]
},
"buyer": {
"id": "GB-NHS-X24",
"name": "NHS ENGLAND"
},
"date": "2025-08-01T11:49:34+01:00",
"id": "045153-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-055064",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PDPT-3135-BWWY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Leeds",
"postalCode": "LS1 4AP",
"region": "UKE42",
"streetAddress": "NHS England, 7\u00268 Wellington Place"
},
"contactPoint": {
"email": "b.kullootee@nhs.net",
"name": "Balram Kullootee"
},
"details": {
"classifications": [
{
"description": "Public authority - central government",
"id": "publicAuthorityCentralGovernment",
"scheme": "UK_CA_TYPE"
}
]
},
"id": "GB-NHS-X24",
"identifier": {
"id": "X24",
"scheme": "GB-NHS"
},
"name": "NHS ENGLAND",
"roles": [
"buyer"
]
},
{
"additionalIdentifiers": [
{
"id": "PQPW-1715-PJLT",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Hemel Hempstead",
"postalCode": "HP2 4TZ",
"region": "UKH23",
"streetAddress": "Ground Floor, Suite A2 Breakspear Way"
},
"details": {
"scale": "sme",
"url": "http://www.orifarm.com",
"vcse": false
},
"id": "GB-COH-10015046",
"identifier": {
"id": "10015046",
"scheme": "GB-COH"
},
"name": "ORIFARM UK LTD",
"roles": [
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PHGH-5788-VVDL",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "EC2M 1QS",
"region": "UKI31",
"streetAddress": "Dashwood House"
},
"details": {
"scale": "large",
"url": "http://www.advanzpharma.com",
"vcse": false
},
"id": "GB-COH-02619880",
"identifier": {
"id": "02619880",
"scheme": "GB-COH"
},
"name": "MERCURY PHARMACEUTICALS LIMITED",
"roles": [
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PDJG-8184-TCQQ",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cambridge",
"postalCode": "CB4 0WA",
"region": "UKH12",
"streetAddress": "216 Cambridge Science Park"
},
"details": {
"scale": "large",
"url": "http://www.amgen.co.uk",
"vcse": false
},
"id": "GB-COH-02354269",
"identifier": {
"id": "02354269",
"scheme": "GB-COH"
},
"name": "AMGEN LIMITED",
"roles": [
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PHRQ-1133-WGCH",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Maidenhead",
"postalCode": "SL6 4UB",
"region": "UKJ11",
"streetAddress": "Abbvie House Vanwall Business Park"
},
"contactPoint": {
"email": "carol.woodland@abbvie.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "http://www.abbvie.co.uk/",
"vcse": false
},
"id": "GB-COH-08004972",
"identifier": {
"id": "08004972",
"scheme": "GB-COH"
},
"name": "ABBVIE LTD",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PYCZ-7339-TCCT",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Hook",
"postalCode": "RG27 9XA",
"region": "UKJ37",
"streetAddress": "Form 1 Bartley Wood Business Park"
},
"contactPoint": {
"email": "catherine.griffiths@alimerasciences.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"url": "http://www.alimerasciences.eu",
"vcse": false
},
"id": "GB-COH-08018355",
"identifier": {
"id": "08018355",
"scheme": "GB-COH"
},
"name": "ALIMERA SCIENCES LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PTGT-3385-PBMQ",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Maidenhead",
"postalCode": "SL6 3UD",
"region": "UKJ11",
"streetAddress": "Building 5 Foundation Park"
},
"contactPoint": {
"email": "bbumarketaccessuk@biogen.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "https://www.biogen-uk-ie.com",
"vcse": false
},
"id": "GB-COH-01497267",
"identifier": {
"id": "01497267",
"scheme": "GB-COH"
},
"name": "BIOGEN IDEC LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PXCG-4172-CHYM",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Welwyn Garden City",
"postalCode": "AL7 1TW",
"region": "UKH23",
"streetAddress": "6 Falcon Way"
},
"contactPoint": {
"email": "welwyn.rx_bdop@roche.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "https://www.roche.co.uk/",
"vcse": false
},
"id": "GB-COH-00100674",
"identifier": {
"id": "00100674",
"scheme": "GB-COH"
},
"name": "ROCHE PRODUCTS LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PJTX-5182-QVLR",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "W12 7FQ",
"region": "UKI33",
"streetAddress": "2nd Floor, The Westworks Building White City Place"
},
"contactPoint": {
"email": "commercial.pricing@novartis.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "https://www.novartis.com/uk-en/",
"vcse": false
},
"id": "GB-COH-00119006",
"identifier": {
"id": "00119006",
"scheme": "GB-COH"
},
"name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PJZQ-1429-ZBVY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "EC3M 7AF",
"region": "UKI31",
"streetAddress": "The Scalpel, 18th Floor"
},
"contactPoint": {
"email": "mark.soderberg@orionpharma.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"url": "http://www.orionpharma.co.uk",
"vcse": false
},
"id": "GB-COH-02281057",
"identifier": {
"id": "02281057",
"scheme": "GB-COH"
},
"name": "ORION PHARMA (UK) LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PGZH-1763-NPGX",
"scheme": "GB-PPON"
}
],
"address": {
"country": "US",
"countryName": "United States",
"locality": "#100 Iselin",
"postalCode": "NJ 08830",
"region": "US",
"streetAddress": "111 S. Wood Ave Unit"
},
"contactPoint": {
"email": "uktenders@OutlookTherapeutics.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"url": "https://outlooktherapeutics.com/",
"vcse": false
},
"id": "GB-COH-08179857",
"identifier": {
"id": "08179857",
"scheme": "GB-COH"
},
"name": "Outlook Therapeutics, Inc.",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PWDD-6894-DXRM",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Castleford",
"postalCode": "WF10 5HX",
"region": "UKE45",
"streetAddress": "Ridings Point"
},
"contactPoint": {
"email": "chrissie.kellett@tevauk.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "http://www.tevauk.com",
"vcse": false
},
"id": "GB-COH-00302461",
"identifier": {
"id": "00302461",
"scheme": "GB-COH"
},
"name": "TEVA UK LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PWYH-6892-QYNN",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Huddersfield",
"postalCode": "HD7 5QH",
"region": "UKE44",
"streetAddress": "Linthwaite Labs Manchester Road"
},
"contactPoint": {
"email": "hospitalcontracts@throntonross.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "https://www.thorntonross.com/",
"vcse": false
},
"id": "GB-COH-00185947",
"identifier": {
"id": "00185947",
"scheme": "GB-COH"
},
"name": "THORNTON \u0026 ROSS LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PWRY-2527-LDRY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Reading",
"postalCode": "RG2 6AD",
"region": "UKJ11",
"streetAddress": "400 South Oak Way"
},
"contactPoint": {
"email": "andrew.asbury@bayer.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "http://www.bayer.co.uk",
"vcse": false
},
"id": "GB-COH-00935048",
"identifier": {
"id": "00935048",
"scheme": "GB-COH"
},
"name": "BAYER PUBLIC LIMITED COMPANY",
"roles": [
"supplier",
"tenderer"
]
},
{
"address": {
"country": "IE",
"countryName": "Ireland",
"locality": "DUBLIN",
"postalCode": "D13 R20R",
"region": "IE",
"streetAddress": "Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13"
},
"contactPoint": {
"email": "uk_tenders@biocon.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"vcse": false
},
"id": "GB-PPON-PQQC-5869-LMVX",
"identifier": {
"id": "PQQC-5869-LMVX",
"scheme": "GB-PPON"
},
"name": "Biosimilar Collaborations Ireland Limited",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PYQL-4248-PXXY",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Uxbridge",
"postalCode": "UB8 1JG",
"region": "UKI74",
"streetAddress": "The Charter Building"
},
"contactPoint": {
"email": "info@celltrionhc.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "https://www.celltrionhealthcare.co.uk",
"vcse": false
},
"id": "GB-COH-11685363",
"identifier": {
"id": "11685363",
"scheme": "GB-COH"
},
"name": "CELLTRION HEALTHCARE UNITED KINGDOM LIMITED",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PMHC-1596-RTNX",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "WC2H 9JQ",
"region": "UKI31",
"streetAddress": "71-75 Shelton Street"
},
"contactPoint": {
"email": "paul.clark@mdbiologics.co.uk"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "sme",
"shelteredWorkshop": false,
"url": "http://www.mdbiologics.co.uk",
"vcse": false
},
"id": "GB-COH-15579040",
"identifier": {
"id": "15579040",
"scheme": "GB-COH"
},
"name": "MDBIOLOGICS LTD",
"roles": [
"supplier",
"tenderer"
]
},
{
"additionalIdentifiers": [
{
"id": "PNQL-1548-CYBZ",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Bracknell",
"postalCode": "RG12 1RF",
"region": "UKJ11",
"streetAddress": "Maxis 1, Western Road"
},
"contactPoint": {
"email": "uk.tenders@sandoz.com"
},
"details": {
"publicServiceMissionOrganization": false,
"scale": "large",
"shelteredWorkshop": false,
"url": "http://www.sandoz.com",
"vcse": false
},
"id": "GB-COH-01547204",
"identifier": {
"id": "01547204",
"scheme": "GB-COH"
},
"name": "SANDOZ LIMITED",
"roles": [
"supplier",
"tenderer"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025 \nOffer reference number: CM/PHS/25/5728\nPeriod of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.\nPotential periods of call-offs under the framework agreement:\nCM/PHS/25/5728/01 - National Framework for Medical Retinal Vascular Treatments:\n7NAT (National) 01/12/2025 to 31/05/2027 (18 months)\nCM/PHS/25/5728/02 - Regional Framework for Medical Retinal Vascular Treatments aflibercept 2mg:\nNOFE: (North of England) 01/12/2025 to 31/05/2027 (18 months) \nSOFE: (South of England) 01/12/2025 to 31/05/2027 (18 months) \nMAE: (Midlands and East) 01/12/2025 to 31/05/2027 (18 months)\nLNW: (London) 01/12/2025 to 31/05/2027 (18 months)\nPublished By: Medicines Procurement and Supply Chain - NHS Medicines Value \u0026 Access, NHS England\t\nProvision of Licensed Medical Retinal Vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England. To include but not limited to aflibercept, bevacizumab, brolucizumab, intravitreal dexamethasone, intravitreal fluocinolone, faricimab and ranibizumab used in the treatment of; \n\u2022 neovascular (wet) age-related macular degeneration (AMD)\n\u2022 visual impairment due to macular oedema secondary to retinal vein occlusion (branch RVO or central RVO)\n\u2022 proliferative diabetic retinopathy (PDR)\n\u2022 visual impairment due to diabetic macular oedema (DME) \n\u2022 visual impairment due to diabetic macular oedema (DME) who are pseudophakic or who are considered insufficiently responsive to, or unsuitable for non-corticosteroid therapy\n\u2022 vision impairment associated with chronic diabetic macular oedema, (DME)\n\u2022 visual impairment due to myopic choroidal neovascularisation (myopic CNV) \n\u2022 retinopathy of prematurity (ROP) with zone I (stage 1+, 2+, 3 or 3+), zone II (stage 2+ or 3+) or AP-ROP (aggressive posterior ROP) disease\n\u2022 inflammation of the posterior segment of the eye presenting as non-infectious uveitis\n\u2022 prevention of relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye",
"id": "C346388",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
},
{
"id": "2",
"status": "complete"
}
],
"procurementMethod": "open",
"procurementMethodDetails": "Open procedure",
"status": "complete",
"techniques": {
"hasFrameworkAgreement": true
},
"title": "NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025"
}
}